Condition: Cervical Cancer · Sponsor: Fundacao Champalimaud
This study will evaluate the role of SBRT with the aim to reproduce high dose rate brachytherapy (HDR BT) dose distribution by means of external beam radiotherapy in the radical treatment in patients with LACC. The study will employ devices to accurately reproduce pelvic anatomy and mitigate target motion and will make use of real-time online tracking.
This description comes directly from the study's public registry record.
Maria Inês Antunes, MD · +351210480200 · ines.antunes@fundacaochampalimaud.pt
Carlo Greco, MD · +351210480200 · carlo.greco@fundacaochampalimaud.pt
Always discuss trial participation with your own doctor first.
| Champalimaud Foundation | Lisbon, Portugal | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06394297